Dr. Goga is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 Divisadero St FL 2
San Francisco, CA 94115Phone+1 415-353-7070Fax+1 415-353-7021
Education & Training
- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1999 - 2001
- David Geffen School of Medicine at UCLAClass of 1997
Certifications & Licensure
- CA State Medical License 1999 - 2026
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Elected Member The American Society for Clinical Investigation, 2011
Clinical Trials
- Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies Start of enrollment: 2012 Mar 27
Publications & Presentations
PubMed
- Tumor Cell Spatial Organization Directs EGFR/RAS/RAF Pathway Primary Therapy Resistance through YAP Signaling.Rachel Nakagawa, Andrew Beardsley, Sophia Durney, Mary-Kate Hayward, Vishvak Subramanyam
Biorxiv. 2024-12-16 - 1 citationsSingle-cell analysis of breast cancer metastasis reveals epithelial-mesenchymal plasticity signatures associated with poor outcomes.Juliane Winkler, Weilun Tan, Catherine Mm Diadhiou, Christopher S McGinnis, Aamna Abbasi
The Journal of Clinical Investigation. 2024-09-03 - 4 citationsThe temporal progression of lung immune remodeling during breast cancer metastasis.Christopher S McGinnis, Zhuang Miao, Daphne Superville, Winnie Yao, Andrei Goga
Cancer Cell. 2024-06-10
Journal Articles
- Aurora Kinase A Drives the Evolution of Resistance to Third-Generation EGFR Inhibitors in Lung CancerVictoria E Wang, Collin M Blakely, Trever G Bivona, Andrei Goga, Nature
- Cancer Cells Exploit an Orphan RNA to Drive Metastatic ProgressionAndrei Goga, MD, Nature
Press Mentions
- A High-Content Screen Identifies the Vulnerability of MYC-Overexpressing Cells to DimethylfasudilMarch 24th, 2021
- $3M Award Lays Foundation for New Scientific Collaborations at Parnassus Heights CampusJanuary 7th, 2021
- ‘Orphan’ RNAs Make Cancer Deadlier, but Potentially Easier to DiagnoseNovember 7th, 2018
- Join now to see all
Research History
- Professor, Dept Cell & Tissue Biology and MedicineOncogene Signaling Activation of proto-oncogenes results in alterations of multiple signaling pathways, resulting in the rewiring of cell proliferation, metabolism and small RNA circuits which contribute to the tumorigenic state. We seek to discover new therapies for patients.2015 - Present
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: